The CCNB1 high expression group had a substantially lower survival time (Including: OS, overall survival; RFS, recurrence free survival; DMFS, distant metastasis free survival) than the CCNB1 low expression group, demonstrating that CCNB1 expression in BC was adversely linked with survival time (Figure 3A). The gene discussed is CCNB1; the disease is breast cancer.